德国美天旎Miltenyi www.miltenyibiotec.com
德国美天旎生物技术公司是一个以细胞分选技术为主、拥有多样化产品的生物技术公司。开发研制并销售世界上最先进的细胞分选、细胞生物学、相关分子生物学产品和技术,尤其在干细胞分选、DC细胞分选与分析、细胞因子分泌细胞分选与分析、免疫治疗、再生医学方面占有极大的优势,CD133、BDCA-2(CD303)、BDCA-4(CD304)单抗为我公司专利产品。
我公司总部位于德国科隆,在科隆和德国北部罗斯托克均有cGMP生产机构。我们的产品有免疫磁珠、特异性细胞及蛋白质或者DNA/RNA分选用的MACS分选设备、单克隆抗体、无菌溶液、基础和特殊培养基、血液/血浆治疗用的生物学吸附剂、LIFE18血浆分离机、流式细胞仪及相关耗材。
德国美天旎生物技术有限公司上海代表处
Miltenyi Biotec, founded in 1989, has grown to over 1100 employees in 18 countries. The company develops, manufactures, and sells more than 1000 products and services; particularly in the fields of cell biology, immunology, regenerative medicine, and molecular biology.
Miltenyi Biotec is committed to the advancement of scientific understanding and medicine by providing products and services for biomedical research and cellular therapy.
Miltenyi Biotec developed MACS® Technology, the gold standard method in magnetic cell separation. The ease and speed of the procedure combined with high purity and yield are only two of its many advantages. MACS Technology combines the use of MACS MicroBeads (nano-sized superparamagnetic particles coupled to specific antibodies), patented MACS Columns, and MACS Separators (strong permanent magnets). MACS Technology offers a multitude of applications: from small-scale to large-scale cell purifications, from cell to biomolecule separations, from lab bench to clinical research applications and separation of adult stem cells – for example, with the CliniMACS® Cell Selection System.
The MACSmolecular Business Unit develops, markets, and sells innovative products for molecular biology research and provides bioinformatics and gene expression profiling services, as well as the generation of transgenic disease models.
The TheraSorb™Therapeutic Apheresis product division offers unique medical instruments, adsorbers, and tubing sets for therapeutic apheresis.
The Miltenyi Bioprocess division manufactures custom biopharmaceuticals, cellular products, medical devices, and related products and services.
Our multidisciplinary R&D departments are constantly developing novel reagents and instruments for use in immunology, cell and molecular biology, bioinformatics, and stem cell technologies – researchers working for researchers.
The technical expertise of the employees is vast. It spans biological and chemical disciplines, including immunology, cell and molecular biology, hematology, regenerative medicine, organic and inorganic chemistry through physics and engineering, including biomedical, electrical, plastics and software development.